Insights from Molecular Precision on Standards & Interoperability.
Biological surveillance does not primarily suffer from a shortage of data. It suffers from an inability to make data generated across different biological domains function as a coherent system.
The instinct to treat biological design data as proprietary is understandable. It is also strategically wrong. Open standards do not erode competitive advantage — they create the conditions in which competitive advantage is possible.